Adrenocorticotropic Hormone-producing Pituitary Tumors: 12- to 22-year Follow-up after Treatment with Stereotactic Radiosurgery
- 1 August 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 49 (2) , 284-292
Abstract
OBJECTIVE: To study retrospectively long-term outcomes of patients with adrenocorticotropic hormone-producing pituitary tumors that were treated with stereotactic Leksell gamma knife unit radiosurgery. METHODS: Eighty-nine patients aged 5 to 67 years were treated between 1976 and 1985. Eighteen patients aged 18 to 68 years (mean age, 41 yr) were followed in detail. Fifteen patients were women. None had previously received conventional radiotherapy, but pituitary microsurgery had been performed in two patients, and one patient had had an adrenalectomy. In the remaining 15 patients, radiosurgery was the primary therapy. RESULTS: Sixty-four patients had one stereotactic treatment, and 25 patients had two or more treatments. No complications were observed during treatment and the immediate follow-up period. At follow-up, 17 patients had died 1 to 20 years after the first treatment. No deaths were related to the treatment. In our 18 patients, the follow-up time after the first radiosurgical treatment was 12 to 22 years (mean follow-up period, 17 yr). Urinary cortisol levels gradually normalized in 83% of the patients. No recurrences were observed. Pituitary hormone insufficiencies developed in about two of every three patients and occurred even more than 10 years after treatment. Eight patients had transient hyperprolactinemia. The patients' vision and visual fields were unaffected, and none of them had signs of radiation-induced side effects such as brain tumors or brain necrosis. CONCLUSION: Stereotactic radiosurgery is a safe and effective method in the treatment of patients with adrenocorticotropic hormone-producing pituitary tumors, and the effect of treatment is long-lasting. Stereotactic radiosurgery is mainly a complement to microsurgery because of its gradually appearing effect and the occurrence of pituitary insufficiency. New pituitary deficiencies may be found more than 10 years after treatment.Keywords
This publication has 31 references indexed in Scilit:
- Pituitary Macroadenoma and Cushing's Disease in Pediatric Patients: Patient Report and Review of the LiteratureJournal of Pediatric Endocrinology and Metabolism, 1998
- The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's DiseaseNew England Journal of Medicine, 1997
- Treatment of secretory pituitary adenoma with radiation therapy.Radiology, 1993
- Hypothalamic-Pituitary Dysfunction after Radiation for Brain TumorsNew England Journal of Medicine, 1993
- Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligandEuropean Journal of Endocrinology, 1991
- TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?Clinical Endocrinology, 1990
- Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's diseaseEuropean Journal of Endocrinology, 1986
- Cushing's DiseaseArchives of internal medicine (1960), 1985
- Cushing' Disease: Management by Transsphenoidal Pituitary Microsurgery*The Journal of Clinical Endocrinology & Metabolism, 1980
- The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1977